182 related articles for article (PubMed ID: 24026753)
41. Valproic acid-induced hyperammonaemic coma and unrecognised portosystemic shunt.
Nzwalo H; Carrapatoso L; Ferreira F; Basilio C
Epileptic Disord; 2013 Jun; 15(2):207-10. PubMed ID: 23774155
[TBL] [Abstract][Full Text] [Related]
42. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
Abreu LN; Issler C; Lafer B
Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
[No Abstract] [Full Text] [Related]
43. Hyperammonemia due to valproic acid in the psychiatric setting.
Carr RB; Shrewsbury K
Am J Psychiatry; 2007 Jul; 164(7):1020-7. PubMed ID: 17606652
[No Abstract] [Full Text] [Related]
44. Hyperammonaemic encephalopathy and a flat electroencephalogram caused by valproic acid.
Belze O; Remérand F; Pujol A; Fusciardi J
Acta Anaesthesiol Scand; 2013 Sep; 57(8):1084. PubMed ID: 23713766
[No Abstract] [Full Text] [Related]
45. Valproate-induced hyperammonemic encephalopathy: a case report.
Shah S; Wang R; Vieux U
J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035
[TBL] [Abstract][Full Text] [Related]
46. Cerebellar atrophy in a child with valproate toxicity.
Ghosh VB; Kapoor S; Prakash A; Bhatt S
Indian J Pediatr; 2011 Aug; 78(8):999-1001. PubMed ID: 21243535
[TBL] [Abstract][Full Text] [Related]
47. Valproate-induced hyperammonemic encephalopathy.
Verrotti A; Trotta D; Morgese G; Chiarelli F
Metab Brain Dis; 2002 Dec; 17(4):367-73. PubMed ID: 12602513
[TBL] [Abstract][Full Text] [Related]
48. [Hyperammonemia secondary to the use of valproic acid: case report].
Turcato Mde F; Fernandes RM; Wichert-Ana L; Funayama CA
Arq Neuropsiquiatr; 2005 Jun; 63(2A):364-6. PubMed ID: 16100994
[TBL] [Abstract][Full Text] [Related]
49. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
[No Abstract] [Full Text] [Related]
50. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
51. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
52. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
Larsen EP; Ostergaard JR
Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
[TBL] [Abstract][Full Text] [Related]
53. Valproate-induced hyperammonemia and seizures: perioperative concerns.
Garg R; Sunder RA
Paediatr Anaesth; 2011 Oct; 21(10):1084-5. PubMed ID: 21981101
[No Abstract] [Full Text] [Related]
54. Burst Suppression Pattern on Electroencephalogram Secondary to Valproic Acid-Induced Hyperammonemic Encephalopathy.
Cherian KA; Legatt AD
Pediatr Neurol; 2017 Aug; 73():88-91. PubMed ID: 28545673
[TBL] [Abstract][Full Text] [Related]
55. Valproate-induced hyperammonemic encephalopathy: a brief review.
Lewis C; Deshpande A; Tesar GE; Dale R
Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
[TBL] [Abstract][Full Text] [Related]
56. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
Mehta S; Tayabali S; Lachmann R
J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
[TBL] [Abstract][Full Text] [Related]
57. Valproic acid-induced hyperammonemia: a case report.
McCall M; Bourgeois JA
J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
[TBL] [Abstract][Full Text] [Related]
58. Valproate-induced hyperammonemic encephalopathy.
Bhatia H; Raman PG
J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
[No Abstract] [Full Text] [Related]
59. Valproate-induced encephalopathy.
Rehman A; Zafar S
J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
[TBL] [Abstract][Full Text] [Related]
60. [A case of valproate-associated hyperammonemia with chronic hepatitis C].
Fukushima M; Kotoh K; Enjoji M; Nakamuta M; Nawata H; Aishima S
Nihon Shokakibyo Gakkai Zasshi; 2005 Jan; 102(1):42-7. PubMed ID: 15682815
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
